Feedback / Questions
neihulizumab (AbGn-168H) - AbGenomics
https://www.globenewswire.com/news-release/2021/03/08/2189016/0/en/AltruBio-s-Neihulizumab-Granted-Fast-Track-Designation-by-the-FDA-for-Steroid-Refractory-Acute-Graft-Versus-Host-Disease.html
Mar 8, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next